Fig. 4From: Formulation and characterization of transdermal patches for controlled delivery of duloxetine hydrochlorideWater vapor absorption studies (a), moisture loss studies (b), water vapor transmission studies (c), and drug content recovery studies (d) for the various formulationsBack to article page